References
- Ganschow R, Albani J, Grabhorn E, Richter A, Burdelski M. Tacrolimus-induced cholestatic syndrome following pediatric liver transplantation and steroid-resistant graft rejection. Pediatr Transplant. 2006;10(2):220–224.
- Taniai N, Akimaru K, Ishikawa YHepatotoxicity caused by both tacrolimus and cyclosporine after living donor liver transplantation. J Nippon Med Sch. 2008;75(3):187–191.
- Sacher VY, Bejarano PA, Pham SM. Tacrolimus induced hepatotoxicity in a patient with bilateral lung transplant. Transpl Int. 2012;25(10):e111–e1112. doi:10.1111/j.1432-2277.2012.01546.x
- Vallet-Pichard A, Rerolle JP, Fontaine HVeno-occlusive disease of the liver in renal transplant patients. Nephrol Dial Transplant. 2003;18(8):1663–1666.
- Soresi M, Sparacino V, Pisciotta GEffects of cyclosporin A on various indices of cholestasis in kidney transplant recipients. Minerva Urol Nefrol. 1995;47(2):65–69.
- Lorber MI, Van Buren CT, Flechner SM, Williams C, Kahan BD. Hepatobiliary complications of cyclosporine therapy following renal transplantation. Transplant Proc. 1987;19(1 Pt 2):1808–1810.
- Yuan QS, Zheng FL, Sun Y, Yu Y, Li Y. Rescue therapy with tacrolimus in renal graft patients with cyclosporine A-induced hepatotoxicity: a preliminary study. Transplant Proc. 2000;32(7):1694–1695.
- Sanchez-Campos S, Lopez-Acebo R, Gonzales P, Culebras JM, Tuñon MJ, Gonzalez-Gallego J. Cholestasis and alterations of glutathione metabolism induced by tacrolimus (FK506) in the rat. Transplantation. 1998;66(1):84–88.